Table 2.
Teratocarcinosarcomas of the female genital tract
| Author [year] |
Age, y | Primary | Diagnosis | Treatment | Stage | Histology | Outcome |
|---|---|---|---|---|---|---|---|
| Ehrmann RL [1990] | 62 | Ovary | TCS | Surgery + chemotherapy | III | SCC, adenocarcinoma, chondrosarcoma, rhabdomyosarcoma |
DOD 27 mo |
| Tanimoto A [2001] | 59 | Ovary | TCS | Surgery | IV | SCC, adenocarcinoma, chondrosarcoma | DOD |
| Garcia-Garvis OF [2008] | 69 | Ovary | TCS | Surgery | IV | SCC, adenocarcinoma, chondrosarcoma, rhabdomyosarcoma, osteosarcoma, liposarcoma, yolk-sac tumor | DOD |
| Matsuura Y [2010] | 40 | Ovary | TCS | Surgery + chemotherapy | II | Adenocarcinoma, chondrosarcoma, endometrial stromal sarcoma |
DOD 46 mo |
| Coutney F [2019] | 55 | Ovary | TCS |
Surgery + chemotherapy |
IC |
Adenocarcinoma, carcinosarcoma, dysgerminoma, primitive retinal tissue primitive neuroepithelial tissue, fetal cartilage |
DOD 14 mo |
| Present case [2019] | 45 | Cervix | TCS | Surgery + radiation | IB2 | Glial-like tissues, immature intestinal glands, cartilage, neuroepithelial tissue, rhabdomyosarcoma |
NED 13 mo |
TCS, Teratocarcinosarcoma; SCC, Squamous cell carcinoma; DOD, Died of disease; NED, No evidence of disease